canakinumab,Atezolizumab,Pembrolizumab
Novartis,Roche,Merck
['agent', 'canakinumab', 'canopy-a']
perspective on canopy-a from dr. - reminder that we have not seen a positive adjuvant study with an agent that has not shown benefit in the metastatic setting. what happens now with canakinumab and the exciting but puzzling cantos results? #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him